Arch Therapeutics Inc (ARTH)

[Ziptrader0]

Yep. Stuck in the doldrums without a paddle. What Arch has is a small group of investors, left over from the Stock Gumshoe debacle who continue to buy small amounts to keep the share price stable. And they have a hard-liner who continues pumping the stock, because he and others own a sizable proportion of the shares and don't want to abandon what appears to me a more and more risky position as more time passes. If MIT doesn't pull the patent license, all Arch will have by early next year at best is approval for a wound dressing,(of which there are tons of competitors), not the holy grail of a hemostat. And they have to raise money soon.I think you are correct, that the stock is headed to the teens. My opinion only. I do not have a position nor do I intend to take one.